Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting

Alexis Ogdie; Christopher T Ritchlin

doi:10.3899/jrheum.201669

Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting

J Rheumatol. 2021 Feb 15:jrheum.201669. doi: 10.3899/jrheum.201669. Online ahead of print.

Authors

Alexis Ogdie¹, Christopher T Ritchlin¹

Affiliation

¹ As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA. AO reports conflicts of interest with Amgen (Forward/National Databank), Novartis (University of Pennsylvania), Pfizer Inc. (University of Pennsylvania), AbbVie, Amgen, Bristol Myers Squibb, Celgene, Corrona, Eli Lilly, Janssen, Novartis, Pfizer Inc., Takeda Pharmaceutical Company, and UCB. CTR reports conflicts of interest with AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer Inc., and UCB. Address correspondence to Dr. A. Ogdie, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alogdie@pennmedicine.upenn.edu.

PMID: 33589545
DOI: 10.3899/jrheum.201669

Abstract

Prior to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Annual Meeting in July 2020, a grant writing workshop was held to cover key principles in grant writing for GRAPPA members. In this review of the workshop, we will present key principles discussed.